Will NCT05063162 (UCB Biopharma SRL) still show a study completion date of 1 July 2027 or earlier when checked on 31 July 2027?
deadline 2027-07-31
confidence medium
tier 4 evidence
70%PolySignal estimate
Resolution criterion
Yes if, when NCT05063162 is read on clinicaltrials.gov on 31 July 2027, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 1 July 2027 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 2 October 2026: NCT05063162 is registered as ACTIVE_NOT_RECRUITING, sponsored by UCB Biopharma SRL, with 113 participants. Started 2022-02; announced primary completion 2027-05-06, announced study completion 2027-07-01. Record last updated 2026-09-25. The date under test is 2027-07-01. Source: clinicaltrials.gov/study/NCT05063162
What pushes it up
- No changes to the study completion date have been made since the last record update, and no negative news or delays have been reported, suggesting the date is likely to remain unchanged [1]
What pushes it down
- The record has not been updated for over a month, and clinical trials often experience delays that push completion dates back, which could reduce the likelihood of the date staying the same [1]
What would move this number most
Whether the trial encounters any operational or regulatory delays that would push the completion date beyond 1 July 2027
How this number is built
| Deadline | 2027-07-31 |
| Base rate | 70% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 65 · 75 (spread 10 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-03 09:01 |
| Model | openai/gpt-oss-20b (Groq) |